Health Care / Hospitals
Releases published in the last 30 days. 
Page 3 of 3
- Sanofi’s Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young children
- 4/22/2026 11:18:17 AM
- • Expanded approval includes children aged one year and above with stage 2 T1D to delay the onset of stage 3 • Tzield is the first disease-modifying therapy for children aged one year and above diagnosed with stage 2 T1D The US Food and Drug Administration (FDA) has approved the supplemental biologic license application for Tzield (teplizumab-mzwv), expanding the …
- The Estée Lauder Companies Publishes Breakthrough Research Linking Sugar Exposure To Skin Cell Aging
- 4/22/2026 3:05:55 AM
- In a breakthrough that may reshape the industry’s understanding of skin aging, scientists at The Estée Lauder Companies have uncovered a new mechanism linking elevated sugar exposure in skin cells to visible and biological signs of skin decline.
- « Previous
- 1
- 2
- 3
- Next »